ManagedFunds.nz

Annual fund charge

0.98%

vs peer avg 0.95%

Risk indicator

6/7

1 = lower risk · 7 = higher risk

5-year return p.a.

Less than 5 years of data

peer avg 6.03%

Fund size

NZ$54.7m

98% growth · 2% income

The Fund invests primarily in growth-oriented Australian listed companies included in the S&P/ASX 300 Index at the time of initial investment and will also have some exposure to cash.
— Hyperion

Key facts

Fund start date

9 July 2024

Min. investment

NZ$20,000

Tax structure

PIE

Capped at your PIR (max 28%)

Top 10 holdings

As at the latest published quarterly fund update.

Full portfolio (xlsx) →
Holding % of fund
Bhp Group Limited Ordinary Fully Paid 10.05%
Fisher & Paykel Healthcare 9.30%
Sigma Pharmaceuticals Limited Ordinary Fully Paid 8.89%
Block Inc. Cdi 1 1 Foreign Exempt Nyse 8.73%
Macquarie Group Ltd 7.59%
Cochlear Limited 5.78%
Hub24 Limited Ordinary Fully Paid 5.45%
Goodman Group 4.00%
Technology One Limited 3.95%
Life360 Inc 3.57%

Documents

Every dated PDS, quarterly fund update and full-portfolio holdings file. Linked from the FMA Disclose register via Sorted Smart Investor.

About this category

Funds investing primarily in shares listed on the NZX (New Zealand) or ASX (Australia), or both as Trans-Tasman portfolios. Includes active stock-pickers and passive index trackers.

About Hyperion

Australian active manager focused on high-quality global growth companies. NZ PIE wrapper issued by FundRock NZ.

Parent: FundRock NZ (issuer)

See all funds from Hyperion →

Head-to-head

Compare Hyperion Australian Growth Companies PIE Fund with…

Side-by-side numbers — fees, returns, risk, fund size, asset mix.

Peer funds

Other Australasian Equities funds

View all →